OncotypeDX

Learn more about Genomic Health's diagnostic tests for breast, colon and prostate cancer, which can help patients and their doctor make better, more informed treatment decisions.

 

Until Every Woman Knows...

Oncotype DX for DCIS

DCIS / Stage 0 breast cancer affects 1 out of every 5 women diagnosed with breast cancer in the U.S. Not all DCIS patients will benefit from the addition of radiation therapy to their treatment. Learn more about the Oncotype DX test for DCIS.

Transforming the Treatment of Cancer

For over a decade, Genomic Health has made genomics an indispensable part of cancer care. Now, we are using next generation technology to transform patient management throughout the cancer journey: from diagnosis to treatment, and monitoring for recurrence. Learn more about how we are making cancer treatment smarter today and tomorrow.

Cancer Doors

Press Releases

August 20, 2015   

Breast Cancer Research and Treatment Publishes Oncotype DX® DCIS Score(TM) Study Conducted in Canada

August 17, 2015   

Genomic Health's Oncotype DX® Prostate Cancer Test Receives Medicare Coverage

All press releases